Search Results 331-340 of 24201 for In situ

1. Breast cancer - Doctors and departments - Mayo Clinic

   ... situ, Lobular carcinoma in situ, Fibroadenoma, Atypical hyperplasia of ... Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida ...

2. A Study Of Astrin Biosciences EV-based Proteomic Assay In Detecting Breast Cancer - Mayo Clinic

   ... in detecting breast cancer in a cohort of women with dense breasts ... Prior history of in situ or invasive malignancy, excluding non-melanoma skin ...

3. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

   Translocation (14;16), and/or translocation (14;20), and/or deletion (17p) by florescence in-situ hybridization (FISH) or cytogenetics; Primary plasma cell ...

4. S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer - Mayo Clinic

   S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer ... situ cervical cancer, adequately treated stage I ...

5. Breast cancer - Doctors and departments - Mayo Clinic

   ... situ, Lobular carcinoma in situ, Fibroadenoma, Atypical hyperplasia of ... Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida ...

6. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

   Researchers at Mayo Clinic are currently studying the use of the fluorescence in situ hybridization (FISH) test in the diagnosis of bile duct cancer in people ...

7. Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors - Mayo Clinic

   There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. ... in situ, or carcinoma in-situ of the cervix ...

8. Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions - Mayo Clinic

   ... in situ hybridization (FISH) break-apart assays] or FGFR pathway mutation/amplification [using next-gen sequencing assays (such as Foundation One)]; assays ...

9. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

   ... in situ hybridization (FISH));; Measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 criteria and which can be ...

10. PAC203: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/μL) (PACIFICA) - Mayo Clinic

    This study is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) therapy in ... in situ breast carcinoma after complete surgical resection.